Systemically delivered checkpoint inhibitors have grown into the cornerstone of immuno-oncology. Now, a team at the Terasaki Institute for Biomedical Innovation in Los Angeles wants to improve the effects of the molecules through local delivery.
Source: Mice data show promise of checkpoint inhibitor delivery depots | Fierce Pharma
